Altogether, the lack of Mmp2 in F1 tumors promoted a higher tumor control, and the immune landscape was characterized by T cell proliferation (indicated by Ki67 expression) and infiltration of cytotoxic T cells, NK cells, cross-presenting CD103+ DCs, and M1 macrophages. This evidence concerns the gene MMP2 and neoplasm.